Differential DNA methylation in blood in nuclear genes that encode mitochondrial proteins in mild cognitive impairment and Alzheimer’s disease
Abstract
Background
Altered mitochondrial function contributes to the pathogenesis of mild cognitive impairment (MCI) and late-onset dementia due to Alzheimer’s disease (AD).
Objective
To test for differential methylation in nuclear genes that encode proteins that participate in mitochondrial function between cognitively unimpaired participants (CU) and those with MCI and AD.
Methods
Recently published whole genome methylation sequencing (WGMS) in blood from CU participants (N=174), and those with MCI (N=99) and AD (N=109) was used to test for differential methylation in 1,121 nuclear genes that encode proteins that participate in mitochondrial function in theHuman Protein Atlas.
Results
Seventy-four nuclear genes that encode proteins that participate in mitochondrial function were differentially methylated between persons with MCI and CU. Seventy-one genes were differentially methylated between persons with AD and CU, and 132 genes were differentially methylated between persons with MCI and AD. Thirteen differentially methylated genes shared between the 3 comparisons support contributions from disrupted metabolism and oxidative stress pathways in AD pathogenesis.
Conclusions
Nuclear genes that encode proteins that participate in mitochondrial glucose metabolism, fatty acid metabolism and oxidative stress pathways are differentially methylated between persons who are CU and those with MCI and AD.
Related articles
Related articles are currently not available for this article.